Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Hybridoma Technology

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Efficacy and safety of electrical cardioversion and catheter ablation during pregnancy: a case review and literature analysis.

Frontiers in cardiovascular medicine·2026

Same author

Macro- and micro-scale mechanical properties and energy evolution analysis during unidirectional freeze-thaw cycling of sandstone.

Scientific reports·2026

Same author

Identification of genes directly regulated by LvBlimp1 in shrimp macrophage-like phagocytes.

Developmental and comparative immunology·2026

Same author

LvBlimp1 and LvHes1 coregulate the function of macrophage-like phagocytes in shrimp hemolymph.

Fish & shellfish immunology·2026

Same author

Transcriptomic profiling and experimental validation of myeloid-cell-differentiation-related key genes in osteoarthritis.

Frontiers in genetics·2026

Same author

Damage characteristics and constitutive modeling of coal under real-time temperatures.

PloS one·2026

Search research articles

Related Experiment Video

Updated: Apr 17, 2026

Laboratory Scale Production and Purification of a Therapeutic Antibody

Laboratory Scale Production and Purification of a Therapeutic Antibody

Published on: January 24, 2017

DualGPT-AB: a dual-stage generative optimization framework for therapeutic antibody design.

Dongna Xie^1,2, Siyuan Chen³, Xi Zeng^1,2

¹AI for Science Interdisciplinary Research Center, School of Computer Science, Northwestern Polytechnical University, Xi'an, China.

Nature Computational Science

|April 15, 2026

Summary

DualGPT-AB, an AI framework, designs therapeutic antibodies by optimizing multiple properties simultaneously. This approach accelerates the development of novel antibodies with enhanced efficacy, including improved tumoricidal activity against HER2-positive cancers.

More Related Videos

Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction

Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction

Published on: September 14, 2018

Scalable High Throughput Selection From Phage-displayed Synthetic Antibody Libraries

Scalable High Throughput Selection From Phage-displayed Synthetic Antibody Libraries

Published on: January 17, 2015

Related Experiment Videos

Last Updated: Apr 17, 2026

Laboratory Scale Production and Purification of a Therapeutic Antibody

Laboratory Scale Production and Purification of a Therapeutic Antibody

Published on: January 24, 2017

Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction

Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction

Published on: September 14, 2018

Scalable High Throughput Selection From Phage-displayed Synthetic Antibody Libraries

Scalable High Throughput Selection From Phage-displayed Synthetic Antibody Libraries

Published on: January 17, 2015

Area of Science:

Biotechnology
Computational Biology
Immunology

Background:

Optimizing therapeutic antibody properties like specificity and immunogenicity is crucial but challenging with current methods.
Existing techniques are time-consuming and struggle to balance multiple antibody characteristics effectively.

Purpose of the Study:

To introduce DualGPT-AB, a novel dual-stage conditional generative pre-trained transformer (GPT) framework for efficient therapeutic antibody design.
To leverage artificial intelligence for simultaneous optimization of multiple antibody properties, enhancing development efficiency.

Main Methods:

Utilized a conditional GPT to model antibody sequence-property relationships using learnable embeddings for desired properties.
Incorporated a reinforcement learning strategy to improve antibody sequence exploration and optimization efficiency.
Generated and computationally validated antibody heavy chain complementarity-determining region 3 (CDRH3) sequences.

Main Results:

DualGPT-AB successfully generated antibody CDRH3 sequences with multiple desired properties.
8% of designed antibodies showed excellent HER2-binding affinities.
Wet-laboratory validation confirmed enhanced tumoricidal activity compared to Herceptin in HER2-positive cancer models.

Conclusions:

DualGPT-AB is a powerful AI-driven approach for therapeutic antibody development.
The framework demonstrates potential for accelerating the design of antibodies with improved efficacy and safety profiles.
This method offers a promising solution for overcoming limitations in traditional antibody engineering.